Secretome vs. PRP Injections for Hair Density and Growth in Androgenetic Alopecia Patients

Recruiting now · Phase 1/Phase 2

Conditions studied: Androgenetic Alopecia

In brief

This study aims to compare the effectiveness of secretome injection and intradermal platelet-rich plasma (PRP) injection on hair density and the terminal-to-vellus hair ratio in patients with androgenetic alopecia at Prof. Dr. I.G.N.G. Ngoerah General Hospital.

Key facts

Study ID

NCT07429253

Run by

PT. Prodia Stem Cell Indonesia

People needed

40

Starts

2026-01-09

Expected to finish

2026-09-30

Last updated by the study team

2026-02-24

Who can join

Age: 25 and older, up to 59. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male patients with androgenetic alopecia, aged 25 to 59 years, with clinical presentation consistent with Hamilton-Norwood grades II to VI, seeking treatment at the Dermatology and Venereology Outpatient Clinic of Prof. Dr. I.G.N.G. Ngoerah General Hospital.
• Female patients with androgenetic alopecia, aged 25 to 59 years, with clinical presentation consistent with Ludwig grades I to III, seeking treatment at the Dermatology and Venereology Outpatient Clinic of Prof. Dr. I.G.N.G. Ngoerah General Hospital.
• Female patients who are not currently pregnant or breastfeeding.
• Patients who have discontinued anti-androgen medication and minoxidil for at least 1 month prior to the procedure.
• Patients with no known allergies to secretome components and/or materials used in the platelet-rich plasma (PRP) preparation process.
• Patients who are proficient in Indonesian and willing to provide written informed consent.

You may not qualify if…

• Participants who are unable to speak or understand Indonesian and/or are unwilling to provide written informed consent.
• Patients presenting with types of hair loss other than androgenetic alopecia.
• Patients currently undergoing therapy with 5-alpha reductase inhibitors.
• Patients who have received intradermal corticosteroid injections to the scalp within at least 6 months prior to the study.
• Patients with active infections and/or active dermatitis on the scalp.
• Patients with a known history of allergy to secretome components and/or materials used in the platelet-rich plasma (PRP) preparation process.
• History of hypertrophic scarring or blood clotting (coagulation) disorders.
• Patients unable to complete the research procedures in their entirety.

Where it is running

• Prof. dr. I.G.N.G. Ngoerah Central General Hospital — Denpasar, Bali, Indonesia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.